surveil
influenza
indispens
time
monitor
respons
outbreak
epidem
influenza
circul
influenza
virus
identifi
system
surveil
program
addit
data
influenza
surveil
applic
evalu
vaccin
effect
select
vaccin
strain
thu
wellconstruct
properli
oper
influenza
surveil
scheme
essenti
public
health
annual
epidem
respiratori
virus
includ
influenza
viru
variou
countri
region
largesc
studi
epidemiolog
respiratori
virus
import
understand
situat
individu
countri
previous
retrospect
analysi
respiratori
virus
perform
patient
respiratori
ill
south
korea
respiratori
viral
etiolog
investig
hospit
neonat
adult
pneumonia
requir
intens
care
also
howev
lack
inform
regard
largesc
multicent
viral
surveil
adult
patient
ili
influenzalik
ill
emerg
depart
ed
studi
involv
first
extens
laboratori
surveil
ili
patient
first
teach
hospitalbas
influenza
surveil
scheme
south
korea
influenza
season
studi
aim
investig
distribut
season
respiratori
virus
detect
adult
patient
ili
visit
ed
seven
teach
hospit
studi
protocol
approv
institut
review
board
irb
hospit
approv
number
korea
univers
guro
hospit
korea
univers
ansan
hospit
hallym
univers
kangnam
sacr
heart
hospit
cathol
univers
st
vincent
hospit
inha
univers
hospit
yonsei
univers
wonju
christian
hospit
chungbuk
nation
univers
hospit
patient
gave
written
inform
consent
studi
conduct
accord
principl
guidelin
express
declar
helsinki
hospitalbas
influenza
morbid
mortal
himm
teach
hospitalbas
clinic
laboratori
influenza
surveil
scheme
south
korea
total
seven
teach
hospit
particip
scheme
influenza
season
two
hospit
seoul
two
hospit
gyeonggi
provinc
ansan
suwon
one
hospit
incheon
one
hospit
gangwon
provinc
wonju
one
hospit
chungcheongbuk
provinc
cheongju
figur
show
map
studi
site
studi
popul
includ
adult
patient
year
visit
ed
ili
week
start
sep
week
end
jun
ili
defin
acut
respiratori
ill
measur
fever
afebril
state
case
antipyret
use
last
eight
hour
least
one
respiratori
symptom
cough
sore
throat
rhinorrhea
andor
nasal
congest
nasopharyng
oropharyng
flock
swab
obtain
ili
patient
flock
swab
place
viral
transport
medium
bd
usa
immedi
store
transfer
laboratori
korea
univers
guro
hospit
seoul
sampl
kept
use
total
rna
extract
viral
transport
medium
contain
flock
swab
use
franc
per
manufactur
protocol
revers
transcript
perform
use
cyclescript
rt
premix
bioneer
korea
random
hexam
use
synthes
cdna
cdna
sampl
store
use
multiplex
pcr
perform
use
ace
detect
seegen
korea
detect
influenza
viru
influenza
b
viru
adenoviru
coronaviru
coronaviru
respiratori
syncyti
viru
rsv
rsv
b
rhinoviru
human
metapneumoviru
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
bocaviru
enteroviru
sampl
test
three
tube
reaction
briefli
ace
primer
mix
multiplex
master
mix
solut
sampl
cdna
mix
tube
denatur
minut
pcr
reaction
perform
use
cycl
second
second
second
follow
extens
minut
among
sampl
test
posit
influenza
viru
select
test
differenti
subtyp
use
influenza
ab
onestep
type
seegen
korea
briefli
solut
random
hexam
flu
ab
onestep
primer
mix
onestep
rtpcr
buffer
onestep
rtpcr
enzym
mix
rnasefre
water
sampl
rna
mix
tube
cycl
condit
includ
revers
transcript
step
minut
denatur
step
minut
pcr
reaction
perform
use
cycl
second
second
second
follow
extens
minut
posit
neg
control
includ
pcr
analysi
electrophoresi
pcr
amplicon
perform
agaros
gel
data
express
median
interquartil
rang
iqr
continu
variabl
count
percent
categor
variabl
fisher
exact
test
use
analyz
categor
variabl
statist
analys
carri
use
spss
spss
inc
chicago
il
usa
p
valu
consid
statist
signific
week
start
sep
week
end
jun
patient
ili
visit
ed
clinic
characterist
patient
shown
tabl
median
age
patient
year
iqr
patient
male
age
distribut
follow
year
year
year
year
least
one
chronic
underli
diseas
found
patient
diabet
mellitu
frequent
comorbid
patient
ili
forti
five
patient
cardiovascular
diseas
among
patient
ili
pregnant
patient
four
hundr
thirti
patient
receiv
influenza
vaccin
season
hospit
visit
vaccin
rate
vari
accord
age
group
year
year
year
year
median
time
initi
symptom
onset
sampl
collect
day
iqr
among
respiratori
specimen
ili
patient
sampl
posit
least
one
respiratori
viru
total
respiratori
virus
detect
figur
tabl
influenza
viru
predomin
agent
among
respiratori
virus
detect
ili
patient
season
promin
viru
detect
two
patient
influenza
b
viru
detect
patient
distribut
influenza
virus
appear
bimod
first
peak
appear
week
start
jan
end
jan
second
peak
present
week
start
mar
end
mar
preponder
influenza
viru
found
first
peak
influenza
b
viru
domin
second
peak
among
respiratori
virus
noninfluenza
respiratori
virus
rhinoviru
detect
patient
circul
throughout
entir
studi
period
exclud
novemb
decemb
human
metapneumoviru
found
patient
appear
around
late
winter
epidem
peak
present
spring
week
apr
rsv
case
occur
winter
episod
spring
singl
detect
bocaviru
enteroviru
epidem
peak
influenza
diverg
accord
age
group
figur
present
earlier
patient
age
year
year
week
jan
week
jan
year
group
week
jan
feb
patient
age
year
proport
respiratori
virus
differ
accord
age
group
also
preval
human
metapneumoviru
higher
patient
year
old
year
group
patient
age
year
adenoviru
detect
patient
age
less
year
old
case
two
respiratori
virus
detect
respiratori
specimen
case
two
respiratori
virus
detect
concurr
tabl
five
patient
influenza
also
found
two
virus
rhinoviru
rsv
rhinoviru
adenoviru
rhinoviru
parainfluenza
viru
influenza
b
viru
rhinoviru
influenza
b
viru
parainfluenza
viru
one
case
six
respiratori
virus
found
simultan
influenza
viru
influenza
b
viru
rhinoviru
rsv
coronaviru
human
metapneumoviru
rhinoviru
frequent
detect
concurr
viru
influenza
patient
case
coincid
influenza
b
comparison
demograph
characterist
patient
singl
viru
multipl
virus
respiratori
specimen
patient
hematolog
malign
vs
p
organ
transplant
recipi
vs
p
higher
rate
coincid
tabl
howev
signific
differ
clinic
outcom
includ
hospit
rate
complic
studi
first
extens
laboratori
surveil
etiolog
respiratori
virus
ili
patient
teach
hospitalbas
influenza
surveil
south
korea
influenza
viru
predomin
agent
major
influenza
viru
season
addit
respiratori
virus
detect
respiratori
specimen
adult
patient
ili
virus
influenza
virus
respiratori
viru
detect
rate
respiratori
specimen
ili
patient
rang
depend
studi
period
characterist
studi
popul
includ
age
type
specimen
circul
virus
analysi
method
least
one
viru
detect
sampl
studi
influenza
viru
predomin
agent
find
consist
report
sinc
ili
clinic
definit
design
detect
potenti
influenza
case
use
ili
casedefinit
make
influenza
virus
virus
like
identifi
casedefinit
suitabl
purpos
himm
surveil
focus
detect
influenza
yu
et
al
investig
respiratori
viral
etiolog
adult
acut
respiratori
tract
infect
visit
ed
china
parainfluenza
viru
found
domin
agent
studi
enrol
criteria
includ
respiratori
symptom
bodi
temperatur
normal
low
leukocyt
count
radiograph
abnorm
chest
differ
respiratori
viral
etiolog
children
adult
rsv
preval
viru
associ
substanti
morbid
children
respiratori
viru
infect
research
studi
popul
includ
adult
patient
viral
etiolog
pediatr
patient
ili
evalu
coincid
rate
respiratori
virus
ili
patient
vari
accord
studi
studi
multipl
respiratori
virus
detect
posit
specimen
total
ili
patient
sampl
clinic
signific
coincid
respiratori
virus
clearli
determin
infant
bronchiol
dual
viral
infect
risk
factor
icu
admiss
coinfect
human
metapneumoviru
rsv
strongli
associ
diseas
sever
addit
viral
coinfect
relat
increas
probabl
hospit
children
respiratori
infect
howev
impact
detect
multipl
respiratori
viral
infect
clinic
outcom
rare
investig
adult
studi
diseas
sever
outcom
differ
significantli
patient
singl
viru
patient
multipl
respiratori
virus
addit
detect
viral
nucleic
acid
respiratori
specimen
alway
suggest
caus
agent
appar
infect
among
respiratori
virus
rhinoviru
common
viru
detect
influenza
patient
one
patient
six
respiratori
virus
detect
simultan
year
old
femal
patient
previous
healthi
outcom
good
without
hospit
complic
sequela
among
coincid
case
two
patient
hospit
influenza
viru
rhinoviru
influenza
viru
rsv
research
viral
interfer
especi
influenza
viru
rhinoviru
requir
anim
model
human
studi
limit
first
surveil
popul
limit
adult
visit
ed
ili
second
evalu
caus
agent
ili
cover
respiratori
virus
bacteri
viral
pathogen
caus
acut
febril
respiratori
ill
investig
third
possibl
low
viral
titer
could
detect
rtpcr
fourth
patient
acut
febril
ill
without
respiratori
ill
could
enrol
studi
recruit
depend
whether
case
met
establish
ili
criteria
final
studi
describ
result
laboratori
data
howev
studi
valuabl
understand
respiratori
viral
etiolog
ili
patient
season
studi
noteworthi
first
extens
laboratori
surveil
adult
ili
patient
teach
hospitalbas
influenza
surveil
scheme
south
korea
